tradmap

RLYB Earnings Rallybio Corp

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$11 -$5 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $429000 $858000 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$75M -$37M $0 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 $2 $6 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $149500 $299000 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$20M $12M $44M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–21 of 21
Q2 20262026-06-306.162026-08-0610-Q
Q1 20262026-03-31-1.462026-05-1310-Q
FY 20252025-12-31-1.592026-03-1610-K
Q3 20252025-09-30-0.072025-11-0610-Q
Q2 20252025-06-30-0.432025-08-0710-Q
Q1 20262025-03-31-1.692026-05-1310-Q
FY 20252024-12-31-10.612026-03-1610-K
Q3 20252024-09-30-1.082025-11-0610-Q
Q2 20252024-06-30-0.832025-08-0710-Q
Q1 20252024-03-31-0.472025-05-0810-Q
FY 20242023-12-31-1.842025-03-1310-K
Q3 20242023-09-30-1.352024-11-0710-Q
Q2 20242023-06-30-0.892024-08-0810-Q
Q1 20242023-03-31-0.432024-05-0910-Q
FY 20232022-12-31-2.092024-03-1210-K
Q3 20232022-09-30-1.652023-11-0910-Q
Q2 20232022-06-30-1.052023-08-0810-Q
Q1 20232022-03-31-0.482023-05-0910-Q
FY 20222021-12-31-1.842023-03-0610-K
Q3 20222021-09-30-1.442022-11-0710-Q
Q2 20222021-06-30-1.092022-08-0810-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.